Key result
Perindopril mitigates left ventricular remodeling in hypertension, while enalapril provides myocardial protection in rats.
Why the study?
Do ACE inhibitors (enalapril and perindopril) attenuate cardiac remodeling in experimental chronic adrenergic stress in rats and in patients with arterial hypertension?
Do ACE inhibitors (enalapril and perindopril) attenuate cardiac remodeling in experimental chronic adrenergic stress in rats and in patients with arterial hypertension?
ACE inhibition with perindopril prevents the progression and reduces the severity of left ventricular remodeling in hypertensive patients, particularly those with high-renin hypertension and hypertrophic remodeling, while enalapril offers moderate myocardial protection in experimental adrenergic stress.
Answers are grounded in this paper and cite their sources.
Does not support practice change; leaves open randomized confirmation of perindopril remodeling benefits.
Morphological changes in the cardiac ventricles were investigated in an experimental model of chronic adrenergic stress in Wistar rats treated with enalapril, as well as echocardiographic parameters in patients with arterial hypertension receiving antihypertensive therapy with perindopril. The study demonstrated that, in the left ventricle, administration of enalapril concurrently with the induction of chronic adrenergic stress produced only a modest protective effect against alterations in myocardial collagen fibers. Enalapril exerted a moderate protective effect on cardiomyocytes and the extracellular spaces of the left ventricular myocardium. Analysis of FGF-2 expression in the myocardium revealed dysregulation of cytokine expression, which was more pronounced in the right ventricle. In the clinical study, the ACE inhibitor perindopril showed the greatest antihypertensive efficacy in patients with the high-renin form of arterial hypertension, consistent with its pathophysiological mechanism of action. Regression of echocardiographic abnormalities was most pronounced in patients with hypertrophic remodeling of the left ventricle. Preservation of normal left ventricular geometry and the transition from concentric left ventricular hypertrophy to concentric remodeling indicate that the ACE inhibitor perindopril is capable of preventing the progression of left ventricular remodeling and reducing its severity.
No takes yet. Share an insight, caveat, or question.
Rumyantsev et al. (2026) studied Arterial hypertension and experimental chronic adrenergic stress. Enalapril (in rats) and perindopril (in patients) was evaluated on Morphological changes in cardiac ventricles (rats) and echocardiographic parameters of left ventricular remodeling (patients). Perindopril prevented progression and reduced severity of left ventricular remodeling in hypertensive patients, while enalapril provided moderate myocardial protection in stressed rats.
Synapse has enriched 10 related papers. Consider them for comparative context: